armcx3 (Proteintech)
Structured Review

Armcx3, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/armcx3/product/Proteintech
Average 93 stars, based on 8 article reviews
Images
1) Product Images from "ARMCX3 regulates ROS signaling, affects neural differentiation and inflammatory microenvironment in dental pulp stem cells"
Article Title: ARMCX3 regulates ROS signaling, affects neural differentiation and inflammatory microenvironment in dental pulp stem cells
Journal: Heliyon
doi: 10.1016/j.heliyon.2024.e37079
Figure Legend Snippet: Primers information.
Techniques Used:
Figure Legend Snippet: Antibodies information.
Techniques Used:
Figure Legend Snippet: ARMCX3 knockdown facilitates neural differentiation of hDPSCs. (A) The expression level of ARMCX3 in Pg-LPS-treated hDPSCs tested via qRT-PCR assay. (B–E) The expression level of ARMCX3 tested by qRT-PCR and Western blot assay . (F) The detection of neural differentiation ability of Pg-LPS-treated hDPSCs. (G) The expression level of neural-specific marker GFAP (neural-specific marker) tested via IF assay. (H) The expression level of GFAP and βIII-Tubulin (neuron specific marker) tested via qRT-PCR assay. Scale bar = 50 μm * p < 0.05, ** p < 0.01, *** p < 0.001.
Techniques Used: Knockdown, Expressing, Quantitative RT-PCR, Western Blot, Marker
Figure Legend Snippet: ARMCX3 knockdown reduces inflammation response in hDPSCs. (A) The protein level of pro-inflammatory cytokines in Pg-LPS-treated hDPSCs determined by ELISA assay. (B) The mRNA level of COX2 and iNOS in Pg-LPS-treated hDPSCs tested via qRT-PCR assay. ** p < 0.01, *** p < 0.001.
Techniques Used: Knockdown, Enzyme-linked Immunosorbent Assay, Quantitative RT-PCR
Figure Legend Snippet: ARMCX3 knockdown suppresses ROS signal in Pg-LPS-treated hDPSCs. (A) The production level of ROS in Pg-LPS-treated hDPSCs detected by IF assay. (B&C) The content of oxidative stress related indicators in Pg-LPS-treated hDPSCs detected by specific kits. (D) The level of Ca 2+ in Pg-LPS-treated hDPSCs. * p < 0.05, ** p < 0.01, *** p < 0.001.
Techniques Used: Knockdown
Figure Legend Snippet: Inhibition of ROS blocks the effects of ARMCX3 on neural differentiation of hDPSCs. (A&B) The expression level of ARMCX3 tested by qRT-PCR and Western blot assay . (C) The production level of ROS detected by IF assay. (D) The detection of neural differentiation ability of hDPSCs. (E) The expression level of GFAP (neural-specific marker) tested via IF assay. (F) The expression level of GFAP and βIII-Tubulin (neuron specific marker) tested via qRT-PCR assay. Scale bar = 50 μm * p < 0.05, ** p < 0.01, *** p < 0.001.
Techniques Used: Inhibition, Expressing, Quantitative RT-PCR, Western Blot, Marker
Figure Legend Snippet: Inhibition of ROS blocks the effects of ARMCX3 on inflammation microenvironment in hDPSCs. (A) The expression level of pro-inflammatory cytokines in Pg-LPS-treated hDPSCs determined by ELISA assay. (B) The mRNA level of COX2 and iNOS in Pg-LPS-treated hDPSCs tested via qRT-PCR assay. ** p < 0.01, *** p < 0.001.
Techniques Used: Inhibition, Expressing, Enzyme-linked Immunosorbent Assay, Quantitative RT-PCR
